0 points, SCA Band 1, 0.000 EFTSL
Postgraduate - Unit
Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.
- Second semester 2019 (On-campus)
Must be enrolled in Doctor of Psychology in Clinical Neuropsychology
The unit will cover the following topics.
- Introduction to drug classifications; legal control of drug use; pharmacokinetics; variability in response to drugs; chemical transmission and receptors.
- Mood disorders: antidepressants and mood stabilizers; anti-anxiety drugs, sedatives and hypnotics, drugs used for OCD, panic, and phobic disorders.
- Psychosis and schizophrenia; anti-psychotic drugs. Cognitive enhancers: ADHD, Alzheimer's disease, brain trauma.
- Drugs of abuse: affects on brain and cognition.
- Delirium; The Mini Mental State Examination.
- Mental health in older adults.
On completion of the unit students should:
- Understand the basic concepts of psychopharmacology with particular reference to recent advances in the fields of psychiatric medication, cognitive enhancers and neuroprotective agents, and substance abuse;
- Have a broad understanding of commonly prescribed psychoactive drugs, legal and illegal drugs and other commonly abused substances.
- Be able to comment on the likely physiological and psychological effects in a particular individual of a specific drug (together with possible drug interactions), and to prepare a written report on the topic.
- Be exposed to current issues in clinical psychopharmacology and in research concerning treatment approaches.
- Gain a broad understanding of the advanced psychopathology topics of delirium, mental health in older adults, and bereavement.
Take-Home Examination (100%)